Cargando…
Systemic Inflammatory Response Index (SIRI) at Baseline Predicts Clinical Response for a Subset of Treatment-Resistant Bipolar Depressed Patients
Background: in a recent double-blind, placebo controlled RCT we demonstrated that selective inhibition of cyclo-oxygenase 2 (COX2) is an effective adjunctive strategy in treatment-resistant bipolar depression (TRBDD). To better clarify the mechanisms underlying TRBDD and treatment response, we condu...
Autores principales: | Murata, Stephen, Baig, Nausheen, Decker, Kyle, Halaris, Angelos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10533150/ https://www.ncbi.nlm.nih.gov/pubmed/37763175 http://dx.doi.org/10.3390/jpm13091408 |
Ejemplares similares
-
Utilizing the Systemic Immune-Inflammation Index and Blood-Based Biomarkers in Association with Treatment Responsiveness amongst Patients with Treatment-Resistant Bipolar Depression
por: Decker, Kyle, et al.
Publicado: (2023) -
Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder
por: Shkundin, Anton, et al.
Publicado: (2023) -
Single nucleotide polymorphisms in C-reactive protein (CRP) predict response to adjunctive celecoxib treatment of resistant bipolar depression
por: Halaris, Angelos, et al.
Publicado: (2023) -
Diminution of Heart Rate Variability in Bipolar Depression
por: Hage, Brandon, et al.
Publicado: (2017) -
iPad & Siri for dummies
por: Baig, Edward C
Publicado: (2012)